| CAS No. |
Product Name |
Formula |
| |
IMMUNOGLOBULIN G, MONKEY, H AND L, HRP |
|
| |
IMMUNOGLOBULIN G, MONKEY, H AND L, TEXAS RED(TM) |
|
| |
IMMUNOGLOBULIN G, MONKEY, H AND L, TRITC |
|
| |
IMMUNOGLOBULIN G, MOUSE, H AND L, AP |
|
| |
IMMUNOGLOBULIN G, RABBIT, H AND L, AP |
|
| |
IMMUNOGLOBULIN G, RAT, H AND L, AP |
|
| |
IMMUNOGLOBULIN G, SHEEP, H AND L, AP |
|
| |
IMMUNOGLOBULIN G, SWINE, H AND L, AP |
|
| |
IMMUNOGLOBULIN G, TURKEY, H AND L, AP |
|
| |
IMMUNOGLOBULIN M, MONKEY, H AND L |
|
| |
INT-H1-S6A,F8A C-MYC INHIBITOR |
|
| |
ISOPROPYL (5-[3-FLUORO-4-(1-PYRROLIDINYL)BENZYLIDENE]-2,4-DIOXO-1,3-THIAZOLIDIN-3-YL)ACETATE |
C19 H21 F N2 O4 S |
| |
IL-1RACP (C2), HUMAN |
C98 H145 N27 O22 |
| |
IL-1RACP (C1), HUMAN |
C97 H164 N32 O36 |
| |
IRAK-2 (C1), HUMAN |
C84 H136 N24 O36 S |
| |
IODOACETAMIDE, [2-14C] |
C2 H4 I N O |
|
9014-51-1
|
INDOLEAMINE 2,3-DIOXYGENASE |
|
| |
IMP:NAD OXIDOREDUCTASE |
|
| |
IN SITU HYBRIDIZATION BLOCKING SOLUTION |
|
| |
IN-SPEC(R) VISIBLE STANDARD 0.05 |
|
| |
IN-SPEC(R) VISIBLE STANDARD 0.1 |
|
| |
IN-SPEC(R) VISIBLE STANDARD 0.5 |
|
| |
IN-SPEC(R) VISIBLE STANDARD 0.8 |
|
| |
IN-SPEC(R) VISIBLE STANDARD 1.0 |
|
| |
IN-SPEC(R) VISIBLE STANDARD 4.0 |
|
| |
IN-SPEC(R) UV STANDARD NO 1 |
|
| |
IN-SPEC(R) UV STANDARD NO 2 |
|
| |
IN-SPEC(R) UV STANDARD NO 20 |
|
| |
IN-SPEC(R) UV STANDARD NO 3 |
|
| |
IN-SPEC(R) UV STANDARD NO 30 |
|
| |
IN-SPEC(R) UV STANDARD NO 4 |
|
| |
IN-SPEC(R) UV STANDARD NO 5 |
|
| |
IN-SPEC(R) UV STANDARD NO 6 |
|
| |
IN-SPEC(R) UV STANDARD NO 7 |
|
| |
IN-SPEC(R) UV STANDARD NO 8 |
|
| |
INSULIN ARG+, ZINC, HUMAN |
|
| |
IL-21 RECEPTOR |
|
|
618443-27-9
|
ISOPROPYL 3-ETHYLPYRROLO(2,1-A)PHTHALAZINE-1-CARBOXYLATE |
C17 H18 N2 O2 |
| |
IMMUNOGLOBULIN G, GUINEA PIG, H AND L |
|
|
140923-27-9
|
ISOPROPOXYCARBONYL-L-VALINE |
C9 H17 N O4 |
| |
IMMUNOGLOBULIN G2B, MOUSE, H AND L, TRITC |
|
| |
ISOPROPYL (2Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)ACETATE |
C8 H9 N O4 S |
| |
ISOPROPYL (5-METHYL-2-OXO-1,3-BENZOXAZOL-3(2H)-YL)ACETATE |
C13 H15 N O4 |
|
199177-25-8
|
ISOPROPYL (4-FORMYLPHENOXY)ACETATE |
C12 H14 O4 |
| |
INDOLINYL-N-PROPYLFORMAMIDE |
C12 H16 N2 O |
| |
INDOLINYL((3-(TRIFLUOROMETHYL)PHENYL)AMINO)METHANE-1-THIONE |
C16 H13 F3 N2 S |
| |
INDOLINYL((4-METHYLPHENYL)AMINO)METHANE-1-THIONE |
C16 H16 N2 S |
| |
INDOL-2-YL 4-PHENYLPIPERAZINYL KETONE |
C19 H19 N3 O |
| |
INDOL-2-YL 4-BENZYLPIPERAZINYL KETONE |
C20 H21 N3 O |
| |
INDOL-2-YL 4-(2-PYRIDYL)PIPERAZINYL KETONE |
C18 H18 N4 O |
| |
INDOL-2-YL 4-PYRIMIDIN-2-YLPIPERAZINYL KETONE |
C17 H17 N5 O |
|
31283-25-7
|
ISOQUINOLINE-3-YL DIPHENYL METHANOL |
C22 H19 N O |
| |
ISOPROPYL (2E)-2-([3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-7-METHYL-3-OXO-5-(2-THIENYL)-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE ACETATE |
C31 H25 Cl N4 O3 S2 . C2 H4 O2 |
|
676645-34-4
|
ISOPROPYL ((4-AMINO-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ACETATE |
C17 H24 N4 O2 S |
| |
ISOPROPYL [(3-ALLYL-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETATE |
C18 H22 N2 O3 S2 |
| |
ISOBUTYL (2E)-5-[4-(ACETYLOXY)-3-ETHOXYPHENYL]-2-(3-CHLOROBENZYLIDENE)-7-METHYL-3-OXO-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE |
C29 H29 Cl N2 O6 S |
| |
ISOLEUCINE BENZYL ESTER P-TOLUENESULFONATE |
C13 H19 N O2 . C7 H8 O3 S |
|
573951-09-4
|
ISOPROPYL ((4-AMINO-5-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ACETATE |
C14 H18 N4 O3 S |
| |
ISOBUTYL (2E)-5-[4-(ACETYLOXY)-3-METHOXYPHENYL]-2-(3,4-DIMETHOXYBENZYLIDENE)-7-METHYL-3-OXO-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE |
C30 H32 N2 O8 S |
|
10092-04-3
|
ISOTENULIN |
C17 H22 O5 |
| |
IKK-ALPHA (C2), HUMAN |
C75 H121 N21 O33 S |
| |
IKK-ALPHA (C3), HUMAN |
C62 H108 N20 O26 |
|
577789-92-5
|
ISOPROPYL ((4-AMINO-5-(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ACETATE |
C13 H15 Cl N4 O2 S |
|
478252-72-1
|
ISONICOTINALDEHYDE [3-METHYL-7-(1-NAPHTHYLMETHYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]HYDRAZONE |
C23 H19 N7 O2 |
|
763108-76-5
|
ISOPROPYL ((4-AMINO-5-(3-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ACETATE |
C13 H15 Cl N4 O2 S |
|
478252-84-5
|
ISONICOTINALDEHYDE [1,3-DIMETHYL-7-(1-NAPHTHYLMETHYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]HYDRAZONE |
C24 H21 N7 O2 |
| |
IKK-ALPHA CONTROL PEPTIDE |
C92 H146 N32 O26 S |
| |
IKK-BETA CONTROL PEPTIDE |
C63 H98 N18 O30 S |
| |
IL-19 |
|
| |
IL-20 |
|
| |
ICP-MS CALIBRATION STANDARD SOLUTION FOR 6020 CLP-M |
|
| |
ICP-MS QC STANDARD SOLUTION 20 |
|
| |
ICP-MS STOCK STANDARD SOLUTION A FOR 200.8 |
|
| |
ITAC BIOTINYL [HOMO SAPIENS] |
|
|
4963-01-3
|
ISOMITRAPHYLLINE |
C21 H24 N2 O4 |
|
60205-81-4
|
IPRATROPIUM |
C20 H30 N O3 |
| |
I-KAPPAB-BETA CONTROL PEPTIDE |
C82 H130 N24 O27 |
|
103205-15-8
|
INDOLE-3-METHYLCARBINOL |
C10 H11 N O |
| |
IN-2-LF |
C81 H150 N42 O17 |
| |
ISOBUTYL-3-(4-CYANOPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE ACETATE |
C16 H18 N2 O3 |
